Agriexpo Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 5.70 Cr
- Company Age 30 Year, 4 Months
- Open Charges ₹ 6.29 Cr
About Agriexpo Biotech (India)
Agriexpo Biotech (India) Limited (ABIL) is a Public Limited Indian Non-Government Company incorporated in India on 19 October 1994 and has a history of 30 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 5.70 Cr and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹6.29 Cr.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1994PLC082153
- Company No.
082153
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Oct 1994
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Agriexpo Biotech (India)?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Agriexpo Biotech (India).
Enhance accessibility to Agriexpo Biotech (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Agriexpo Biotech (India)?
Unlock access to Agriexpo Biotech (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹6.29 Cr
₹0
Charges Breakdown by Lending Institutions
- Icici Banking Corporation Ltd. : 3.00 Cr
- The Industrial Credit & Investment Corporation Of India Ltd. : 1.25 Cr
- Agriexpo Board (India) Ltd. : 1.00 Cr
- Corporation Bank : 1.00 Cr
- Development Credit Bank Ltd. : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 1996 | Corporation Bank | ₹1.00 Cr | Open |
| 07 Sep 1996 | The Industrial Credit & Investment Corporation Of India Ltd. | ₹1.25 Cr | Open |
| 07 Mar 1996 | Agriexpo Board (India) Ltd. | ₹1.00 Cr | Open |
| 24 Aug 1995 | Development Credit Bank Ltd. | ₹0.35 M | Open |
| 25 Jul 1995 | Icici Banking Corporation Ltd. | ₹3.00 Cr | Open |
How Many Employees Work at Agriexpo Biotech (India)?
Unlock and access historical data on people associated with Agriexpo Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agriexpo Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agriexpo Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.